Compositions and Methods Relating to Clonal Progenitor Cells
OwnerMichael West, James T Murai +1inventors
InventorsMichael West, James T Murai, Jay Yang
Life of this patent
Estimating the term…
Abstract
Aspects of the present invention include methods and compositions related to the production and use of clonal lineages of embryonic progenitor cell lines derived from differentiating cultures of primordial stem cells. In particular, said methods and compositions relate to methods of differentiating cells in the presence of agents that inhibit the signaling of the TGF beta family members of growth factors and the applications of said cell lines in the treatment of diseases such as degenerative muscle disorders, cancer, and vascular disease.
Claims15
1-8. (canceled)
An in vitro endothelial progenitor cell line that expresses the markers PECAM1, vWF, and CDH5 (VE-cadherin).
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses ITLN1.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses ITLN2.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses POSTN.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses MAMDC2.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses APLNR.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses APLN.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line expresses NPTX2.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line is clonal.
The in vitro endothelial progenitor cell line of claim 1, wherein the endothelial progenitor cell line is the in vitro progeny of a hES cell.
A method of differentiating a hES cell into an endothelial cell comprising:
- a) contacting the hES cell with activin and wnt;
- b) contacting the cells of a) with activin without wnt;
- c) contacting the cells of b) with FGF and BMP;
- d) contacting the cells of c) with a TGFβ inhibitor.
Dependencies are inferred from the claim text.